Journal
Oncoimmunology
Publication Date
5-9-2024
Volume
13
Issue
1
First Page
2351255
Document Type
Open Access Publication
DOI
10.1080/2162402X.2024.2351255
Rights and Permissions
Mu-Mosley H, von Itzstein MS, Fattah F, Liu J, Zhu C, Xie Y, Wakeland EK, Park JY, Kahl BS, Diefenbach CS, Gerber DE. Distinct autoantibody profiles across checkpoint inhibitor types and toxicities. Oncoimmunology. 2024 May 9;13(1):2351255. doi: 10.1080/2162402X.2024.2351255. © 2024 The Author(s). Published with license by Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
Recommended Citation
Mu-Mosley, Hong; von Itzstein, Mitchell S; Fattah, Farjana; Liu, Jialiang; Zhu, Chengsong; Xie, Yang; Wakeland, Edward K; Park, Jason Y; Kahl, Brad S; Diefenbach, Catherine S; and Gerber, David E, "Distinct autoantibody profiles across checkpoint inhibitor types and toxicities." Oncoimmunology. 13, 1. 2351255 (2024).
https://digitalcommons.wustl.edu/oa_4/4066
Additional Links
Supplemental material is available for this article at publisher site.
